|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 209/12 | (2006.01) |
| A61K 31/454 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 3350163 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16767235.1 |
| Date of filing the European patent application | 2016-09-15 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation | 2020-04-10 |
| (86) | Number | PCT/EP2016/071852 |
| Date | 2016-09-15 |
| (87) | Number | WO 2017/046258 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| 15185522 | 2015-09-16 | EP | |
| 16163465 | 2016-04-01 | EP |
| (72) |
KESTELEYN, Bart Rudolf Romanie, BE
RABOISSON, Pierre Jean-Marie Bernard, BE
BONFANTI, Jean-Francois, FR
JONCKERS, Tim Hugo Maria, BE
BARDIOT, Dorothée Alice Marie-Eve, BE
MARCHAND, Arnaud Didier M, BE
|
| (73) |
Janssen Pharmaceuticals, Inc.,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven, K.U. Leuven R&D Waaistraat 6 Box 5105, 3000 Leuven, BE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Mono- arba dipakeistieji indolo dariniai kaip dengės viruso replikacijos slopikliai |
| MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2022-10-17 | 7 | 243.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-09-15 |